0001193125-20-138283 Sample Contracts

GALECTIN THERAPEUTICS INC. Common Stock (par value $0.001 per share) At The Market Issuance Sales Agreement

At the Market Issuance Sales Agreement • May 11th, 2020 • Galectin Therapeutics Inc • Pharmaceutical preparations • New York

• Contract Type
  At the Market Issuance Sales Agreement
• Filed
  May 11th, 2020
• Company
  Galectin Therapeutics Inc
• Industry
  Pharmaceutical preparations
• Jurisdiction
  New York

Galectin Therapeutics Inc., a Nevada corporation (the “Company”), confirms its agreement (this “Agreement”), with H.C. Wainwright & Co., LLC (“Wainwright”), as follows: